Editorial Policies

Focus and Scope

eJIM, the eJournal of Indian medicine, is a multidisciplinary periodical founded in 2007 by Jan Meulenbeld (1928 - 2016) and Roelf Barkhuis that publishes studies on traditional South Asian medical traditions by qualified scholars in philology, medicine, pharmacology, botany, anthropology and sociology. Authors from India, Sri Lanka and adjoining countries are cordially invited to contribute.

eJIM specifically encourages original approaches with fresh perspectives and daring methodologies to discussions in the abovementioned fields.

eJIM does not publish:
- pharmacological articles without accompanying clinical studies
- ethnobotanical articles without a discussion of medical uses and healing rationalities.

eJIM is an Open Access publication and makes no charge either to authors or to readers. All articles and the Archives can be accessed without registration. Registered users, however, will be notified by email on publication of an issue of the journal, new books, or news items.

The counterpart of eJIM is ABIM, the Annotated Bibliography of Indian Medicine, maintained by Jan Meulenbeld. See the link ABIM, top menu, right.

 

Section Policies

Articles

Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Reviews

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed
 

Peer Review Process

The review process is kept simple and short.

Submissions will be either accepted or rejected. Individual members of the editorial board may veto a submission because it does not meet expected scholarly standards.

Articles will be accepted or rejected within four weeks after submission. We strive to publish accepted papers within six weeks after acceptation. This, in combination with our Open Access Policy, will allow us to quickly and widely disseminate scientific work.

 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.